ALK and non-small cell lung carcinoma: An overseas phase I study (PROFILE 1001) [28] and an international joint phase II study (PROFILE 1005) were conducted in patients with ALK-positive NSCLC and showed favorable results by the fluorescence in situ hybridization (FISH) method.